e.p.t.q. S500 Lidocaine by JETEMA Co., Ltd. is a premium dermal filler formulated with highly purified, four-times cross-linked hyaluronic acid at a concentration of 24 mg/ml. The product is manufactured using the proprietary HIVE™ cross-linking technology, which is designed to support high viscoelasticity, structural stability, and controlled tissue integration.
Due to its high density and robust rheological properties, e.p.t.q. S500 Lidocaine is suitable for deep tissue applications requiring pronounced structural support and contour definition. The gel allows precise shaping while maintaining a natural appearance and stable results over time.
The formulation includes lidocaine to improve patient comfort during injection. e.p.t.q. S500 Lidocaine is supplied sterile, ready to use, and must be administered exclusively by qualified healthcare professionals in an appropriate clinical setting.
When used by trained medical professionals, e.p.t.q. S500 Lidocaine is intended to:
- support deep volumisation and structural contouring
- enhance facial definition and projection
- contribute to improved facial balance
- maintain natural-looking and harmonious results
Typical areas of application include:
- cheekbones
- chin
- jawline
- cheeks
- other areas requiring deep volumetric support
The duration and outcome of treatment may vary depending on individual anatomy, injection technique, and patient-specific factors.
Each package of e.p.t.q. S500 Lidocaine contains:
- Hyaluronic Acid – 24 mg/g
Highly purified, four-times cross-linked hyaluronic acid (HIVE™ technology).
- Lidocaine – 0.3%
Included to enhance comfort during the injection procedure.
- Package contents:
1 sterile pre-filled syringe with 1.1 ml of product.
Important Notice:
e.p.t.q. S500 Lidocaine is a CE-certified medical device intended for professional use only.
Administration must be performed exclusively by qualified healthcare professionals.
This product information is provided for informational purposes only and does not replace medical advice or professional training.
Indications, contraindications, and treatment suitability must be assessed by the treating practitioner in accordance with the official instructions for use.